Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies
This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal.
Furkejuvvon:
| Materiálatiipa: | Online |
|---|---|
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Fáttát: | |
| Liŋkkat: | ONIX_20230808_9783036583112_73 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
| _version_ | 1869526419859570688 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal. |
| format | Online |
| id | doab-20.500.12854ir-112567 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1125672024-03-31T13:10:43Z Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies Biersack, Bernhard illudin M retinoic acid neuronal cells brain tumors anticancer agents PROTAC target protein protein degradation indication cinnamic acid derivatives antiproliferative activity microtubule tubulin stabilizer pterostilbene melanoma anticancer activity apoptosis proliferation hepatocellular carcinoma eIF4A1 translation inhibitors targeted therapies heat shock proteins Hsp70 Hsp40 anticancer eEF1A mechanism macrocycle heterocycle gold carbene ligands metal-based drugs esophageal cancer carbonic anhydrases colorectal cancer consensus molecular subtypes CMS SLC-0111 targeted inhibition of carbonic anhydrases chemotherapy curcumin difluorinated curcumin CDF pancreatic cancer PDAC 2-hydroxypropyl-β-cyclodextrin cyclodextrin adenosine deaminases acting on RNA (ADAR) anti-ADAR2 natural products cancer depression anxiety disorders autism spectrum disorder (ASD) molecular docking molecular dynamics simulation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology This Special Issue covers a well-balanced collection of state-of-the-art topics in the prospering and competitive field of anticancer drug design and development, which can address and inspire oncologists, biologists, and medicinal chemists among the readership of this journal. 2023-08-08T15:28:04Z 2023-08-08T15:28:04Z 2023 book ONIX_20230808_9783036583112_73 9783036583112 9783036583105 https://directory.doabooks.org/handle/20.500.12854/112567 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7693 https://mdpi.com/books/pdfview/book/7693 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-8310-5 10.3390/books978-3-0365-8310-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036583112 9783036583105 268 Basel open access |
| spellingShingle | illudin M retinoic acid neuronal cells brain tumors anticancer agents PROTAC target protein protein degradation indication cinnamic acid derivatives antiproliferative activity microtubule tubulin stabilizer pterostilbene melanoma anticancer activity apoptosis proliferation hepatocellular carcinoma eIF4A1 translation inhibitors targeted therapies heat shock proteins Hsp70 Hsp40 anticancer eEF1A mechanism macrocycle heterocycle gold carbene ligands metal-based drugs esophageal cancer carbonic anhydrases colorectal cancer consensus molecular subtypes CMS SLC-0111 targeted inhibition of carbonic anhydrases chemotherapy curcumin difluorinated curcumin CDF pancreatic cancer PDAC 2-hydroxypropyl-β-cyclodextrin cyclodextrin adenosine deaminases acting on RNA (ADAR) anti-ADAR2 natural products cancer depression anxiety disorders autism spectrum disorder (ASD) molecular docking molecular dynamics simulation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title | Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title_full | Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title_fullStr | Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title_full_unstemmed | Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title_short | Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies |
| title_sort | recent advances of novel pharmaceutical designs for anti cancer therapies |
| topic | illudin M retinoic acid neuronal cells brain tumors anticancer agents PROTAC target protein protein degradation indication cinnamic acid derivatives antiproliferative activity microtubule tubulin stabilizer pterostilbene melanoma anticancer activity apoptosis proliferation hepatocellular carcinoma eIF4A1 translation inhibitors targeted therapies heat shock proteins Hsp70 Hsp40 anticancer eEF1A mechanism macrocycle heterocycle gold carbene ligands metal-based drugs esophageal cancer carbonic anhydrases colorectal cancer consensus molecular subtypes CMS SLC-0111 targeted inhibition of carbonic anhydrases chemotherapy curcumin difluorinated curcumin CDF pancreatic cancer PDAC 2-hydroxypropyl-β-cyclodextrin cyclodextrin adenosine deaminases acting on RNA (ADAR) anti-ADAR2 natural products cancer depression anxiety disorders autism spectrum disorder (ASD) molecular docking molecular dynamics simulation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | illudin M retinoic acid neuronal cells brain tumors anticancer agents PROTAC target protein protein degradation indication cinnamic acid derivatives antiproliferative activity microtubule tubulin stabilizer pterostilbene melanoma anticancer activity apoptosis proliferation hepatocellular carcinoma eIF4A1 translation inhibitors targeted therapies heat shock proteins Hsp70 Hsp40 anticancer eEF1A mechanism macrocycle heterocycle gold carbene ligands metal-based drugs esophageal cancer carbonic anhydrases colorectal cancer consensus molecular subtypes CMS SLC-0111 targeted inhibition of carbonic anhydrases chemotherapy curcumin difluorinated curcumin CDF pancreatic cancer PDAC 2-hydroxypropyl-β-cyclodextrin cyclodextrin adenosine deaminases acting on RNA (ADAR) anti-ADAR2 natural products cancer depression anxiety disorders autism spectrum disorder (ASD) molecular docking molecular dynamics simulation n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230808_9783036583112_73 |